[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334427-105":59,"doc-detail-334427-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","distinct-patterns-of-proteostasis-network-gene-expression-are-associated-with-different-prognoses-in-melanoma-patients","Distinct patterns of proteostasis network gene expression are associated with different prognoses in melanoma patients","","Proteostasis network (PN) genes reflect protein folding and degradation pathways that maintain proteome integrity across cellular compartments. While PN gene expression differences are known in many cancers and PN inhibition can slow growth, survival-linked variation across individual melanoma patients remains unclear. Hierarchical clustering of gene expression from primary and metastatic cutaneous melanoma identified two distinct patient groups per sample type, defined by ATP-dependent/independent chaperones and proteasomal subunits. These PN signatures associate with distinct transcription factor activity and markedly different survival outcomes, yet similar PN alterations can still yield discordant prognoses between primary and metastatic disease.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/distinct-patterns-of-proteostasis-network-gene-expression-are-associated-with-different-prognoses-in-melanoma-patients/334427/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/distinct-patterns-of-proteostasis-network-gene-expression-are-associated-with-different-prognoses-in-melanoma-patients/334427.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the proteostasis network, and why is it important in melanoma?","Question",{"text":112,"@type":113},"The proteostasis network comprises pathways that manage protein folding, refolding, and degradation to preserve proteome integrity. In cutaneous melanoma, tumor cells rely heavily on these components to survive proteotoxic stress.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study analyze proteostasis network gene expression?",{"text":117,"@type":113},"Unbiased hierarchical clustering was applied to gene expression data from primary and metastatic cutaneous melanoma samples. This produced two distinct patient groups within each sample type.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find about prognosis and survival outcomes?",{"text":121,"@type":113},"Patient groups differed by expression of genes encoding ATP-dependent and ATP-independent chaperones and proteasomal subunits. These differences corresponded to distinct transcription factor profiles and markedly different survival outcomes, though similar PN alterations could still associate with discordant prognosis between primary and metastatic samples.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334427,1790197954,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nDistinct patterns of proteostasis network gene expression are associated with different prognoses in melanoma patients  \nRachel Wellman1,2, Daniel Jacobson2,3, Maria Secrier2* & John Labbadia1*  \nThe proteostasis network (PN) is a collection of protein folding and degradation pathways that spans cellular compartments and acts to preserve the integrity of the proteome. The differential expression of PN genes is a hallmark of many cancers, and the inhibition of protein quality control factors is an effective way to slow cancer cell growth. However, little is known about how the expression of PN genes differs between patients and how this impacts survival outcomes. To address this, we applied unbiased hierarchical clustering to gene expression data obtained from primary and metastatic cutaneous melanoma (CM) samples and found that two distinct groups of individuals emerge across each sample type. These patient groups are distinguished by the differential expression of genes encoding ATP-dependent and ATP-independent chaperones, and proteasomal subunits. Differences in PN gene expression were associated with increased levels of the transcription factors, MEF2A, SP4, ZFX, CREB1 and ATF2, as well as markedly different survival outcomes. However, surprisingly, similar PN alterations in primary and metastatic samples were associated with discordant survival outcomes in patients. Our findings reveal that the expression of PN genes demarcates CM patients and highlights several new proteostasis sub-networks that could be targeted for more effective suppression of CM within specific individuals.  \nCutaneous melanoma (CM), the deadliest form of skin cancer, occurs following the malignant transformation of melanocytes1. Exposure to UV radiation is the most significant risk factor, with 75% of cases being attributed to UV exposure2. The disease is becoming increasingly common as numbers of people who have low skin pigmentation travel to and live in countries with high levels of sunlight, and as use of UV sun beds continues. The International Agency for Research on Cancer (part of the World Health Organisation) has predicted that between 2020 and 2040 numbers of new cases of melanoma will increase by 50% and deaths will increase by 68%3. This not only causes human suffering but also places an increasing financial burden on public health services. New treatments for melanoma, particularly immunotherapy and targeted therapies, have improved prognosis, and many cases are now treated successfully, with mortality rates in the United States declining by around 4% per year since 2015, despite incidence increasing4. However, heterogeneity within and between tumours, anda tendency towards increased drug resistance, lead to relatively high rates of recurrence and fatality. This variability in clinical outcomes has motivated extensive research to identify clinical and genetic factors that may aid prognosis and the development of new treatments, as well as the improved targeting of existing treatments.  \nA key feature of many cancers, including melanoma, is a dependency on the protein homeostasis (proteostasis) network (PN) for tumorigenesis and growth. The PN is a large and intricate network of protein quality control pathways and stress responses that maintains the quality, quantity and location of a cell’s proteins in the face of damage caused by cytotoxic stressors, including toxic chemicals, radiation and ageing5. Components of the PN work together to maintain proteostasis by folding and localising new proteins, unfolding and refolding damaged proteins and degrading any proteins that are beyond repair5, thereby protecting the integrity of theproteome and ensuring cell viability.  \nIn CM, as in other cancers, the PN is extensively remodelled to prevent proteotoxicity that would otherwise be caused by elevated protein load, stoichiometric imbalances of protein complexes an","cbCaigcF6xfEU9uY","https://ap.wps.com/l/cbCaigcF6xfEU9uY","pdf",2601031,15,"English","# Introduction\n## Proteostasis network and its role in cancer\n## Proteostasis alterations in cutaneous melanoma\n# Study approach and clustering results\n## Patient stratification by PN gene expression\n## Transcription factor differences and survival association\n# Discussion\n## Discordant outcomes across primary vs metastatic samples\n## Targetable PN sub-networks for melanoma suppression","[{\"question\":\"What is the proteostasis network, and why is it important in melanoma?\",\"answer\":\"The proteostasis network comprises pathways that manage protein folding, refolding, and degradation to preserve proteome integrity. In cutaneous melanoma, tumor cells rely heavily on these components to survive proteotoxic stress.\"},{\"question\":\"How did the study analyze proteostasis network gene expression?\",\"answer\":\"Unbiased hierarchical clustering was applied to gene expression data from primary and metastatic cutaneous melanoma samples. This produced two distinct patient groups within each sample type.\"},{\"question\":\"What did the study find about prognosis and survival outcomes?\",\"answer\":\"Patient groups differed by expression of genes encoding ATP-dependent and ATP-independent chaperones and proteasomal subunits. These differences corresponded to distinct transcription factor profiles and markedly different survival outcomes, though similar PN alterations could still associate with discordant prognosis between primary and metastatic samples.\"}]","Distinct patterns of proteostasis network gene expression are associated with different prognoses in melanoma patients | PDF",1790006598,38]